Brief: Bellicum Pharmaceuticals enters a cancer research grant contract with cancer prevention and research institute of Texas
15/08/2017 21:20
Aug 15 (Reuters) - Bellicum Pharmaceuticals Inc BLCM.O :
* Bellicum Pharmaceuticals says on Aug. 9, entered a cancer
research grant contract with cancer prevention and research
institute of Texas
* Bellicum Pharmaceuticals- under agreement CPRIT awarded
grant of about $16.9 million to bellicum to fund research of a
cancer therapy involving BPX-501
* Bellicum Pharmaceuticals Inc - Bellicum and CPRIT will
retain joint ownership over any intellectual property developed
under agreement
* Bellicum Pharmaceuticals Inc - agreement will expire on
February 29, 2020
Source text: (http://bit.ly/2uZvr0X)
Further company coverage: BLCM.O
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Bellicum Pharmaceuticals
See all newsBrief: Bellicum Pharmaceuticals- In Connection With Dissolution And Plan Of Dissolution, On February 23, Richard A. Fair Resigned As President And Co's CEO
Brief: Bellicum Pharmaceuticals Says Board Approved Liquidation And Dissolution Of Co In Connection With Approval Of Asset Purchase Agreement
Brief: Bellicum Pharmaceuticals Initiated A 12 Stock Split On Dec 8, 2022
Brief: Bellicum Reports Third Quarter 2022 Financial Results And Provides Operational Update
Bellicum Pharmaceuticals Inc expected to post a loss of 64 cents a share - Earnings Preview